Global Peripheral Arterial Disease (PAD) Therapeutics Market Research Report 2026(Status and Outlook)
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Peripheral Arterial Disease (PAD) Therapeutics market size was estimated at USD 3259.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peripheral Arterial Disease (PAD) Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peripheral Arterial Disease (PAD) Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peripheral Arterial Disease (PAD) Therapeutics market.
Global Peripheral Arterial Disease (PAD) Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
AnGes MG, Inc. (Japan)
Athersys, Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics, Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)
Market Segmentation (by Type)
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peripheral Arterial Disease (PAD) Therapeutics Market
Overview of the regional outlook of the Peripheral Arterial Disease (PAD) Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Arterial Disease (PAD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peripheral Arterial Disease (PAD) Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Peripheral Arterial Disease (PAD) Therapeutics market size was estimated at USD 3259.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peripheral Arterial Disease (PAD) Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peripheral Arterial Disease (PAD) Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peripheral Arterial Disease (PAD) Therapeutics market.
Global Peripheral Arterial Disease (PAD) Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
AnGes MG, Inc. (Japan)
Athersys, Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics, Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)
Market Segmentation (by Type)
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peripheral Arterial Disease (PAD) Therapeutics Market
Overview of the regional outlook of the Peripheral Arterial Disease (PAD) Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Arterial Disease (PAD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peripheral Arterial Disease (PAD) Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Key Market Segments
1.2.1 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
1.2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Product Life Cycle
3.3 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
3.8.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peripheral Arterial Disease (PAD) Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peripheral Arterial Disease (PAD) Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peripheral Arterial Disease (PAD) Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2020-2025)
6.4 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2020-2025)
7 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Sales by Application (2020-2025)
7.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2025)
8 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SALES BY REGION
8.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region
8.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.3.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.4.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.5.2 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.6.2 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.7.2 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Peripheral Arterial Disease (PAD) Therapeutics by Region(2020-2025)
9.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peripheral Arterial Disease (PAD) Therapeutics Production
9.4.1 North America Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peripheral Arterial Disease (PAD) Therapeutics Production
9.5.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peripheral Arterial Disease (PAD) Therapeutics Production (2020-2025)
9.6.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peripheral Arterial Disease (PAD) Therapeutics Production (2020-2025)
9.7.1 China Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AstraZeneca Plc. (UK)
10.1.1 AstraZeneca Plc. (UK) Basic Information
10.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.1.4 AstraZeneca Plc. (UK) Business Overview
10.1.5 AstraZeneca Plc. (UK) SWOT Analysis
10.1.6 AstraZeneca Plc. (UK) Recent Developments
10.2 Bayer HealthCare Pharmaceuticals (Germany)
10.2.1 Bayer HealthCare Pharmaceuticals (Germany) Basic Information
10.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.2.4 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
10.2.5 Bayer HealthCare Pharmaceuticals (Germany) SWOT Analysis
10.2.6 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
10.3 Bristol-Myers Squibb Company (US)
10.3.1 Bristol-Myers Squibb Company (US) Basic Information
10.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.3.4 Bristol-Myers Squibb Company (US) Business Overview
10.3.5 Bristol-Myers Squibb Company (US) SWOT Analysis
10.3.6 Bristol-Myers Squibb Company (US) Recent Developments
10.4 Merck and Co., Inc. (US)
10.4.1 Merck and Co., Inc. (US) Basic Information
10.4.2 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.4.3 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.4.4 Merck and Co., Inc. (US) Business Overview
10.4.5 Merck and Co., Inc. (US) Recent Developments
10.5 Proteon Therapeutics, Inc. (US)
10.5.1 Proteon Therapeutics, Inc. (US) Basic Information
10.5.2 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.5.4 Proteon Therapeutics, Inc. (US) Business Overview
10.5.5 Proteon Therapeutics, Inc. (US) Recent Developments
10.6 Sanofi S.A. (France)
10.6.1 Sanofi S.A. (France) Basic Information
10.6.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.6.4 Sanofi S.A. (France) Business Overview
10.6.5 Sanofi S.A. (France) Recent Developments
10.7 Symic Bio, Inc. (US)
10.7.1 Symic Bio, Inc. (US) Basic Information
10.7.2 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.7.4 Symic Bio, Inc. (US) Business Overview
10.7.5 Symic Bio, Inc. (US) Recent Developments
10.8 TheraVasc Inc. (US)
10.8.1 TheraVasc Inc. (US) Basic Information
10.8.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.8.4 TheraVasc Inc. (US) Business Overview
10.8.5 TheraVasc Inc. (US) Recent Developments
10.9 AnGes MG, Inc. (Japan)
10.9.1 AnGes MG, Inc. (Japan) Basic Information
10.9.2 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.9.4 AnGes MG, Inc. (Japan) Business Overview
10.9.5 AnGes MG, Inc. (Japan) Recent Developments
10.10 Athersys, Inc. (US)
10.10.1 Athersys, Inc. (US) Basic Information
10.10.2 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.10.4 Athersys, Inc. (US) Business Overview
10.10.5 Athersys, Inc. (US) Recent Developments
10.11 Betagenon AB (Sweden)
10.11.1 Betagenon AB (Sweden) Basic Information
10.11.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.11.4 Betagenon AB (Sweden) Business Overview
10.11.5 Betagenon AB (Sweden) Recent Developments
10.12 miRagen Therapeutics, Inc. (US)
10.12.1 miRagen Therapeutics, Inc. (US) Basic Information
10.12.2 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.12.4 miRagen Therapeutics, Inc. (US) Business Overview
10.12.5 miRagen Therapeutics, Inc. (US) Recent Developments
10.13 Multi Gene Vascular Systems Ltd (Israel)
10.13.1 Multi Gene Vascular Systems Ltd (Israel) Basic Information
10.13.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.13.4 Multi Gene Vascular Systems Ltd (Israel) Business Overview
10.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
10.14 ViroMed Co. Ltd. (Korea)
10.14.1 ViroMed Co. Ltd. (Korea) Basic Information
10.14.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.14.4 ViroMed Co. Ltd. (Korea) Business Overview
10.14.5 ViroMed Co. Ltd. (Korea) Recent Developments
11 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast
11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region
11.2.4 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peripheral Arterial Disease (PAD) Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Peripheral Arterial Disease (PAD) Therapeutics by Type (2026-2035)
12.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Peripheral Arterial Disease (PAD) Therapeutics by Type (2026-2035)
12.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Key Market Segments
1.2.1 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
1.2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Product Life Cycle
3.3 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
3.8.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peripheral Arterial Disease (PAD) Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peripheral Arterial Disease (PAD) Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peripheral Arterial Disease (PAD) Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2020-2025)
6.4 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2020-2025)
7 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Sales by Application (2020-2025)
7.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2025)
8 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SALES BY REGION
8.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region
8.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.3.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.4.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.5.2 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.6.2 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.7.2 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Peripheral Arterial Disease (PAD) Therapeutics by Region(2020-2025)
9.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peripheral Arterial Disease (PAD) Therapeutics Production
9.4.1 North America Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peripheral Arterial Disease (PAD) Therapeutics Production
9.5.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peripheral Arterial Disease (PAD) Therapeutics Production (2020-2025)
9.6.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peripheral Arterial Disease (PAD) Therapeutics Production (2020-2025)
9.7.1 China Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AstraZeneca Plc. (UK)
10.1.1 AstraZeneca Plc. (UK) Basic Information
10.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.1.4 AstraZeneca Plc. (UK) Business Overview
10.1.5 AstraZeneca Plc. (UK) SWOT Analysis
10.1.6 AstraZeneca Plc. (UK) Recent Developments
10.2 Bayer HealthCare Pharmaceuticals (Germany)
10.2.1 Bayer HealthCare Pharmaceuticals (Germany) Basic Information
10.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.2.4 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
10.2.5 Bayer HealthCare Pharmaceuticals (Germany) SWOT Analysis
10.2.6 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
10.3 Bristol-Myers Squibb Company (US)
10.3.1 Bristol-Myers Squibb Company (US) Basic Information
10.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.3.4 Bristol-Myers Squibb Company (US) Business Overview
10.3.5 Bristol-Myers Squibb Company (US) SWOT Analysis
10.3.6 Bristol-Myers Squibb Company (US) Recent Developments
10.4 Merck and Co., Inc. (US)
10.4.1 Merck and Co., Inc. (US) Basic Information
10.4.2 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.4.3 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.4.4 Merck and Co., Inc. (US) Business Overview
10.4.5 Merck and Co., Inc. (US) Recent Developments
10.5 Proteon Therapeutics, Inc. (US)
10.5.1 Proteon Therapeutics, Inc. (US) Basic Information
10.5.2 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.5.4 Proteon Therapeutics, Inc. (US) Business Overview
10.5.5 Proteon Therapeutics, Inc. (US) Recent Developments
10.6 Sanofi S.A. (France)
10.6.1 Sanofi S.A. (France) Basic Information
10.6.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.6.4 Sanofi S.A. (France) Business Overview
10.6.5 Sanofi S.A. (France) Recent Developments
10.7 Symic Bio, Inc. (US)
10.7.1 Symic Bio, Inc. (US) Basic Information
10.7.2 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.7.4 Symic Bio, Inc. (US) Business Overview
10.7.5 Symic Bio, Inc. (US) Recent Developments
10.8 TheraVasc Inc. (US)
10.8.1 TheraVasc Inc. (US) Basic Information
10.8.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.8.4 TheraVasc Inc. (US) Business Overview
10.8.5 TheraVasc Inc. (US) Recent Developments
10.9 AnGes MG, Inc. (Japan)
10.9.1 AnGes MG, Inc. (Japan) Basic Information
10.9.2 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.9.4 AnGes MG, Inc. (Japan) Business Overview
10.9.5 AnGes MG, Inc. (Japan) Recent Developments
10.10 Athersys, Inc. (US)
10.10.1 Athersys, Inc. (US) Basic Information
10.10.2 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.10.4 Athersys, Inc. (US) Business Overview
10.10.5 Athersys, Inc. (US) Recent Developments
10.11 Betagenon AB (Sweden)
10.11.1 Betagenon AB (Sweden) Basic Information
10.11.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.11.4 Betagenon AB (Sweden) Business Overview
10.11.5 Betagenon AB (Sweden) Recent Developments
10.12 miRagen Therapeutics, Inc. (US)
10.12.1 miRagen Therapeutics, Inc. (US) Basic Information
10.12.2 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.12.4 miRagen Therapeutics, Inc. (US) Business Overview
10.12.5 miRagen Therapeutics, Inc. (US) Recent Developments
10.13 Multi Gene Vascular Systems Ltd (Israel)
10.13.1 Multi Gene Vascular Systems Ltd (Israel) Basic Information
10.13.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.13.4 Multi Gene Vascular Systems Ltd (Israel) Business Overview
10.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
10.14 ViroMed Co. Ltd. (Korea)
10.14.1 ViroMed Co. Ltd. (Korea) Basic Information
10.14.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.14.4 ViroMed Co. Ltd. (Korea) Business Overview
10.14.5 ViroMed Co. Ltd. (Korea) Recent Developments
11 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast
11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region
11.2.4 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peripheral Arterial Disease (PAD) Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Peripheral Arterial Disease (PAD) Therapeutics by Type (2026-2035)
12.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Peripheral Arterial Disease (PAD) Therapeutics by Type (2026-2035)
12.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
Table 5. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2025)
Table 11. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2020-2025)
Table 32. Global Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application
Table 34. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
Table 35. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2020-2025)
Table 39. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025)
Table 44. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. AstraZeneca Plc. (UK) Basic Information
Table 63. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 64. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. AstraZeneca Plc. (UK) Business Overview
Table 66. AstraZeneca Plc. (UK) SWOT Analysis
Table 67. AstraZeneca Plc. (UK) Recent Developments
Table 68. Bayer HealthCare Pharmaceuticals (Germany) Basic Information
Table 69. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 70. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 72. Bayer HealthCare Pharmaceuticals (Germany) SWOT Analysis
Table 73. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
Table 74. Bristol-Myers Squibb Company (US) Basic Information
Table 75. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 76. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Company (US) Business Overview
Table 78. Bristol-Myers Squibb Company (US) SWOT Analysis
Table 79. Bristol-Myers Squibb Company (US) Recent Developments
Table 80. Merck and Co., Inc. (US) Basic Information
Table 81. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 82. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck and Co., Inc. (US) Business Overview
Table 84. Merck and Co., Inc. (US) Recent Developments
Table 85. Proteon Therapeutics, Inc. (US) Basic Information
Table 86. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 87. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Proteon Therapeutics, Inc. (US) Business Overview
Table 89. Proteon Therapeutics, Inc. (US) Recent Developments
Table 90. Sanofi S.A. (France) Basic Information
Table 91. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 92. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi S.A. (France) Business Overview
Table 94. Sanofi S.A. (France) Recent Developments
Table 95. Symic Bio, Inc. (US) Basic Information
Table 96. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 97. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Symic Bio, Inc. (US) Business Overview
Table 99. Symic Bio, Inc. (US) Recent Developments
Table 100. TheraVasc Inc. (US) Basic Information
Table 101. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 102. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. TheraVasc Inc. (US) Business Overview
Table 104. TheraVasc Inc. (US) Recent Developments
Table 105. AnGes MG, Inc. (Japan) Basic Information
Table 106. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 107. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. AnGes MG, Inc. (Japan) Business Overview
Table 109. AnGes MG, Inc. (Japan) Recent Developments
Table 110. Athersys, Inc. (US) Basic Information
Table 111. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 112. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Athersys, Inc. (US) Business Overview
Table 114. Athersys, Inc. (US) Recent Developments
Table 115. Betagenon AB (Sweden) Basic Information
Table 116. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 117. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Betagenon AB (Sweden) Business Overview
Table 119. Betagenon AB (Sweden) Recent Developments
Table 120. miRagen Therapeutics, Inc. (US) Basic Information
Table 121. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 122. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. miRagen Therapeutics, Inc. (US) Business Overview
Table 124. miRagen Therapeutics, Inc. (US) Recent Developments
Table 125. Multi Gene Vascular Systems Ltd (Israel) Basic Information
Table 126. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 127. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Multi Gene Vascular Systems Ltd (Israel) Business Overview
Table 129. Multi Gene Vascular Systems Ltd (Israel) Recent Developments
Table 130. ViroMed Co. Ltd. (Korea) Basic Information
Table 131. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 132. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. ViroMed Co. Ltd. (Korea) Business Overview
Table 134. ViroMed Co. Ltd. (Korea) Recent Developments
Table 135. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Peripheral Arterial Disease (PAD) Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
Table 5. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2025)
Table 11. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2020-2025)
Table 32. Global Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application
Table 34. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
Table 35. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2020-2025)
Table 39. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025)
Table 44. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. AstraZeneca Plc. (UK) Basic Information
Table 63. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 64. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. AstraZeneca Plc. (UK) Business Overview
Table 66. AstraZeneca Plc. (UK) SWOT Analysis
Table 67. AstraZeneca Plc. (UK) Recent Developments
Table 68. Bayer HealthCare Pharmaceuticals (Germany) Basic Information
Table 69. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 70. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 72. Bayer HealthCare Pharmaceuticals (Germany) SWOT Analysis
Table 73. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
Table 74. Bristol-Myers Squibb Company (US) Basic Information
Table 75. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 76. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Company (US) Business Overview
Table 78. Bristol-Myers Squibb Company (US) SWOT Analysis
Table 79. Bristol-Myers Squibb Company (US) Recent Developments
Table 80. Merck and Co., Inc. (US) Basic Information
Table 81. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 82. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck and Co., Inc. (US) Business Overview
Table 84. Merck and Co., Inc. (US) Recent Developments
Table 85. Proteon Therapeutics, Inc. (US) Basic Information
Table 86. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 87. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Proteon Therapeutics, Inc. (US) Business Overview
Table 89. Proteon Therapeutics, Inc. (US) Recent Developments
Table 90. Sanofi S.A. (France) Basic Information
Table 91. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 92. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi S.A. (France) Business Overview
Table 94. Sanofi S.A. (France) Recent Developments
Table 95. Symic Bio, Inc. (US) Basic Information
Table 96. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 97. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Symic Bio, Inc. (US) Business Overview
Table 99. Symic Bio, Inc. (US) Recent Developments
Table 100. TheraVasc Inc. (US) Basic Information
Table 101. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 102. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. TheraVasc Inc. (US) Business Overview
Table 104. TheraVasc Inc. (US) Recent Developments
Table 105. AnGes MG, Inc. (Japan) Basic Information
Table 106. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 107. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. AnGes MG, Inc. (Japan) Business Overview
Table 109. AnGes MG, Inc. (Japan) Recent Developments
Table 110. Athersys, Inc. (US) Basic Information
Table 111. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 112. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Athersys, Inc. (US) Business Overview
Table 114. Athersys, Inc. (US) Recent Developments
Table 115. Betagenon AB (Sweden) Basic Information
Table 116. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 117. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Betagenon AB (Sweden) Business Overview
Table 119. Betagenon AB (Sweden) Recent Developments
Table 120. miRagen Therapeutics, Inc. (US) Basic Information
Table 121. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 122. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. miRagen Therapeutics, Inc. (US) Business Overview
Table 124. miRagen Therapeutics, Inc. (US) Recent Developments
Table 125. Multi Gene Vascular Systems Ltd (Israel) Basic Information
Table 126. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 127. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Multi Gene Vascular Systems Ltd (Israel) Business Overview
Table 129. Multi Gene Vascular Systems Ltd (Israel) Recent Developments
Table 130. ViroMed Co. Ltd. (Korea) Basic Information
Table 131. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 132. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. ViroMed Co. Ltd. (Korea) Business Overview
Table 134. ViroMed Co. Ltd. (Korea) Recent Developments
Table 135. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Peripheral Arterial Disease (PAD) Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Peripheral Arterial Disease (PAD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Product Life Cycle
Figure 13. Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Peripheral Arterial Disease (PAD) Therapeutics
Figure 19. Global Peripheral Arterial Disease (PAD) Therapeutics Market PEST Analysis
Figure 20. Global Peripheral Arterial Disease (PAD) Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type
Figure 27. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2025
Figure 29. Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2020-2025)
Figure 30. Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application
Figure 33. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2025
Figure 37. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country in 2024
Figure 45. U.S. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peripheral Arterial Disease (PAD) Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country in 2024
Figure 55. Germany Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region in 2024
Figure 68. China Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country in 2024
Figure 82. Brazil Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peripheral Arterial Disease (PAD) Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Peripheral Arterial Disease (PAD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Product Life Cycle
Figure 13. Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Peripheral Arterial Disease (PAD) Therapeutics
Figure 19. Global Peripheral Arterial Disease (PAD) Therapeutics Market PEST Analysis
Figure 20. Global Peripheral Arterial Disease (PAD) Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type
Figure 27. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2025
Figure 29. Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2020-2025)
Figure 30. Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application
Figure 33. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2025
Figure 37. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country in 2024
Figure 45. U.S. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peripheral Arterial Disease (PAD) Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country in 2024
Figure 55. Germany Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region in 2024
Figure 68. China Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country in 2024
Figure 82. Brazil Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peripheral Arterial Disease (PAD) Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Application (2026-2035)
